相关实验视频
Updated: Jun 29, 2025

06:44
A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion
Published on: February 28, 2021
4.0K
胰腺脂肪变化的药理景观
1School of Medicine, University of Auckland, Auckland, New Zealand. max.petrov@gmail.com.
Drugs
|April 4, 2024
概括
药物重新定位对治疗常见疾病脂肪胰腺有希望. 本综述详细介绍了用于减少胰腺脂肪沉积的12种药物类别,指导未来的研究和临床实践.
科学领域:
- 胃肠病学和肝病学
- 药理学 药理学是指药理学的学科.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 胰腺内脂肪沉积是一种普遍的胰腺疾病,没有批准的向疗法.
- 药物再利用为管理这种情况提供了一个有希望的途径.
- 脂肪胰腺的治疗场景在很大程度上仍未被探索.
研究的目的:
- 审查和综合针对内脂肪沉积的药物的证据.
- 确定有前途的药物类别进行进一步的研究和临床开发.
- 提供从临床前试验到临床试验的研究层次概述.
主要方法:
- 对研究研究药物来减少胰腺脂肪的综合文献搜索.
- 将已识别的毒品分为12个不同的类别进行分类.
- 证据的层次陈述,包括临床前,回顾性,前性和随机对照试验数据.
主要成果:
- 已经研究了12种类型的药物,以确定它们降低胰腺内脂肪的潜力.
- 证据范围从基础科学研究到人类临床试验,包括随机对照试验.
- 目前还没有批准任何特定的药物,这凸显了进一步研究的必要性.
结论:
- 药物重新定位具有治疗脂肪胰腺的巨大潜力.
- 整合基础科学和强大的临床试验的结构化方法对于推进治疗选择至关重要.
- 对最有前途的药物类别的持续调查是有必要的,以建立有效的治疗方法.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
86
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
86
Chronic Pancreatitis I: Introduction
87
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
87
Glucagon-like Receptor Agonists
321
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
321
Acute Pancreatitis II: Clinical Manifestations and Management
122
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
122
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.2K
Hormones Regulating Blood Glucose
3.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.3K

